Back

Genomic epidemiology of SARS-CoV-2 in Sudan: A retrospective analysis 2020-2022

Mburu, M. W.; Lambisia, A. W.; Elnegoumi, M.; Nour, E. O. M.; Khair, O. M. M.; Abualas, E.; Elhassan, R. M.; Adam, M. A. M.; Mohammed, K. S.; Morobe, J. M.; Ndwiga, L.; Moraa, E. O.; Makori, T. O.; Murunga, N.; Katama, E. N.; Waruguru, D. W.; Githinji, G.; Mwangi, S.; Tessema, S. K.; Adam, M. H. E.; Mahmoud, I.; Mohamed, H. S.; Mustafa, Y. A. A.; Mohamed, M. M. A.; Ahmed, R. H. A.; Mohamed, N. Y. I.; Ali, R. H.; Ebraheem, R. S. M.; Ahmed, H. H. H.; Abdalla, H. E.; Mukhtar, I.; Alla, A. E. M. W.; Elsheikh, O. H. A.; Musa, A. O.; Faki, M. T.; Ahmed, G. M.; Ahmed, T. E. R.; Abdalla, M. A. O.; Moh

2023-11-27 genetic and genomic medicine
10.1101/2023.11.27.23299044 medRxiv
Show abstract

SARS-CoV-2 was first detected in Sudan on 13th March 2020. Here, we describe the genomic epidemiology of SARS-CoV-2 in Sudan between May 2020 and April 2022 to understand the introduction and transmission of SARS-CoV-2 variants in the country. A total of 667 SARS-CoV-2 positive samples were successfully sequenced using the nCoV-19 Artic protocol on the Oxford Nanopore Technology ([≥]70% genome completeness). The genomes were compared with a select contemporaneous global dataset to determine genetic relatedness and estimate import/export events. The genomes were classified into 37 Pango lineages within the ancestral strain (107 isolates across 13 Pango lineages), Eta variant of interest (VOI) (78 isolates in 1 lineage), Alpha variant of concern (VOC) (10 isolates in 2 lineages), Beta VOC (26 isolates in 1 lineage), Delta VOC (171 isolates across 8 lineages) and Omicron VOC (242 isolates across 12 lineages). We estimated a total of 144 introductions of the observed variants from different countries across the globe. Multiple introductions of the Eta VOI, Beta VOC and Omicron VOC were observed in Sudan mainly from Europe and Africa. These findings suggest a need for continuous genomic surveillance of SARS-CoV-2 to monitor their introduction and spread consequently inform public health measures to combat SARS-CoV-2 transmission.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
International Journal of Infectious Diseases
129 papers in training set
Top 0.1%
12.6%
2
Viruses
332 papers in training set
Top 0.4%
9.0%
3
PLOS ONE
5266 papers in training set
Top 21%
7.9%
4
Scientific Reports
3612 papers in training set
Top 10%
6.8%
5
Heliyon
152 papers in training set
Top 0.5%
5.2%
6
Informatics in Medicine Unlocked
22 papers in training set
Top 0.2%
4.1%
7
Microbial Genomics
225 papers in training set
Top 0.9%
3.3%
8
Data in Brief
14 papers in training set
Top 0.1%
2.5%
50% of probability mass above
9
Genomics
64 papers in training set
Top 0.6%
2.1%
10
Virus Research
37 papers in training set
Top 0.3%
2.1%
11
PLOS Neglected Tropical Diseases
466 papers in training set
Top 3%
2.1%
12
Pathogens
56 papers in training set
Top 0.4%
2.1%
13
Epidemiology and Infection
89 papers in training set
Top 1.0%
1.9%
14
Journal of Medical Virology
140 papers in training set
Top 1%
1.7%
15
Journal of General Virology
53 papers in training set
Top 0.5%
1.7%
16
Frontiers in Genetics
230 papers in training set
Top 3%
1.7%
17
Vaccines
198 papers in training set
Top 2%
1.5%
18
iScience
1154 papers in training set
Top 25%
1.1%
19
Archives of Virology
15 papers in training set
Top 0.2%
1.1%
20
Open Forum Infectious Diseases
142 papers in training set
Top 2%
1.1%
21
BMC Genomics
406 papers in training set
Top 7%
1.1%
22
Journal of Infection
78 papers in training set
Top 1%
1.0%
23
Journal of Hospital Infection
29 papers in training set
Top 0.4%
1.0%
24
Frontiers in Microbiology
427 papers in training set
Top 7%
1.0%
25
Royal Society Open Science
214 papers in training set
Top 6%
0.9%
26
Computational and Structural Biotechnology Journal
242 papers in training set
Top 7%
0.9%
27
International Journal of Molecular Sciences
494 papers in training set
Top 15%
0.9%
28
Infection, Genetics and Evolution
42 papers in training set
Top 0.8%
0.9%
29
Transboundary and Emerging Diseases
37 papers in training set
Top 0.5%
0.9%
30
Travel Medicine and Infectious Disease
14 papers in training set
Top 0.5%
0.6%